Better Therapeutics, Inc.

Mountain Crest Acquisition Corp. II, trading on Nasdaq under the ticker MCAD and sponsored by Mountain Crest Capital LLC, completed its initial public offering in early 2021 with a focus on the healthcare and technology sectors. The blank-check company announced and executed a business combination with Better Therapeutics, Inc., a digital health company developing prescription digital therapeutics designed to treat cardiometabolic conditions including type 2 diabetes through behavioral science. The 10-Q filed with the SEC on November 23, 2021 reflects the company's financial position following the close of that business combination in late October 2021, with the merged entity subsequently listing on Nasdaq under the ticker BTTX. Sign up at SpacDesk for full filing histories, sponsor profiles, and deal timelines across the entire SPAC universe.